A splice altering variant in NDRG1 gene causes Charcot-Marie-Tooth disease, type 4D.
Pooja PravinbabuVikram V HollaPrashant PhulpagarNitish KambleManjunath NetravathiRavi YadavPramod Kumar PalBabylakshmi MuthusamyPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2022)
Charcot-Marie-Tooth disease, type 4D (CMT4D) is a progressive, autosomal recessive form of CMT, characterized by distal muscle weakness and atrophy, foot deformities, severe motor sensory neuropathy, and sensorineural hearing impairment. Mutations in NDRG1 gene cause neuropathy in humans, dogs, and rodents. Here, we describe clinical and genetic features of a 17-year-old male with wasting of hand muscle and foot and severe motor neuropathy. Whole exome sequencing was carried out on the patient and his unaffected parents. We identified a novel deletion of nine nucleotides (c.537 + 2_537 + 10del) on the splice donor site of intron 8 in NDRG1 gene. The Sanger sequencing confirmed the segregation of this mutation in autosomal recessive inheritance. Furthermore, transcript analysis confirmed a splice defect and reveals using of an alternate cryptic splice donor site on the downstream intronic region. It resulted in an insertion of 42 nucleotides to exon 8 of NDRG1. Translation of the resulting transcript sequence revealed an insertion of 14 amino acids in-frame to the existing NDRG1 protein. This insertion is predicted to disrupt an alpha helix which is involved in protein-protein interactions in homologous proteins. Our study expands the clinical and genetic spectrum of CMT4D. The splice defect we found in this patient reveals a novel splice isoform of NDRG1 as the potential cause for the neuropathy observed in this patient.
Keyphrases
- genome wide
- copy number
- case report
- amino acid
- mitochondrial dna
- skeletal muscle
- single cell
- multiple sclerosis
- genome wide identification
- dna methylation
- hearing loss
- intellectual disability
- rna seq
- gene expression
- autism spectrum disorder
- risk assessment
- climate change
- drug induced
- dna binding
- binding protein
- duchenne muscular dystrophy